Book Prostate Health Index (PHI) Test | Lahalak Medical Platform

An advanced blood test combining three distinct PSA markers to provide a highly accurate probability score for prostate cancer, significantly improving specificity and reducing the need for unnecessary biopsies.

Scientific name: Prostate Health Index (PHI) Test

The PHI test is a sophisticated blood analysis measuring total PSA, free PSA, and p2PSA. It calculates a risk score for prostate cancer, offering superior clinical specificity for men over 50.

Prostate Health Index (PHI) Test - Advanced Prostate Cancer Risk Assessment
Service type Laboratory test
Duration 10-15 minutes
Fasting Fasting is not required

Included Services

  • Professional blood sample collection
  • Total and Free PSA analysis
  • p2PSA measurement
  • Prostate Health Index (PHI) calculation

Medical Service Information

Why is this test needed?

  • To differentiate between benign prostate conditions and cancer.
  • To reduce the number of unnecessary and invasive prostate biopsies.
  • To evaluate cases with slightly elevated total PSA levels.

Target Groups

  • Men aged 50 and older.
  • Individuals with a family history of prostate cancer.
  • Men with total PSA levels in the 'gray zone' (4-10 ng/mL).

Benefits of the PHI Test

  • Three times more specific for prostate cancer than PSA alone.
  • Assists physicians in making more informed biopsy decisions.
  • Provides a single, comprehensive risk score for clinical clarity.

Conditions & Notices

  • Preferably performed before a digital rectal exam
  • Avoid ejaculation for 48 hours prior to the test

Medical services you might also like